Roche Holding AG
(OTC:RHHBY)
Roche is a Swiss biopharmaceutical and diagnostic company. The firm's bestselling pharmaceutical products include a variety of oncology therapies from acquired partner Genentech, and its diagnostics group was bolstered by the acquisition of Ventana in 2008. Oncology products account for 50% of pharmaceutical sales, and centralized and point-of-care diagnostics for more than half of diagnostic-related sales.
top performing RHHBY trades
Recent Trades
Largest Trades
Top Performing
Largest Traders
Most Active Traders
Recent Trades
View the most recent Roche Holding trades made by congress members.
Josh GottheimerHouse (D-NJ) | $1K - $15K | stock | Purchase | Aug 15, 2024 | Jul 23, 2024 | House |
Josh GottheimerHouse (D-NJ) | $1K - $15K | stock | Sale | Jul 09, 2024 | Jun 21, 2024 | House |
Daniel GoldmanHouse (D-NY) | $50K - $100K | stock | Sale | Aug 13, 2023 | Jul 10, 2023 | House |
Josh GottheimerHouse (D-NJ) | $1K - $15K | stock | Sale | Jun 11, 2023 | May 16, 2023 | House |
Daniel GoldmanHouse (D-NY) | $1K - $15K | stock | Purchase | Apr 17, 2023 | Mar 31, 2023 | House |
Daniel MeuserHouse (R-PA) | $1K - $15K | stock | Sale (Partial) | Apr 25, 2023 | Mar 27, 2023 | House |
Daniel MeuserHouse (R-PA) | $1K - $15K | stock | Sale | Mar 30, 2023 | Feb 28, 2023 | House |
Daniel GoldmanHouse (D-NY) | $15K - $50K | stock | Sale (Partial) | Mar 20, 2023 | Feb 27, 2023 | House |
Daniel GoldmanHouse (D-NY) | $15K - $50K | stock | Purchase | Feb 24, 2023 | Jan 13, 2023 | House |
Dwight EvansHouse (D-PA) | $1K - $15K | stock | Purchase | Nov 21, 2022 | Nov 14, 2022 | House |
John RutherfordHouse (R-FL) | $1K - $15K | stock | Sale | Apr 19, 2022 | Mar 16, 2022 | House |